Abstract
AS a family of structurally-related enzymes, cytochrome P450 (P450) monooxygenases exhibit paradoxical characteristics: although collectively the enzymes display a broad range of substrate specificities, individually they are characterized by a high degree of substrate and product selectivity. Mouse P45015α, and P450coh, for example, which are expressed in female liver and male kidney cells1,2, catalyse 15α-hydroxylation of Δ4 3-ketone steroids, such as testosterone and 7-hydroxylation of coumarin, respectively3–6. In spite of their divergent catalytic activities, however, these enzymes differ by only 11 amino acids within their 494 residues5. To determine the structural basis of the different substrate specificities of P45015α and P450coh we therefore altered each of these 11 residues by site-directed mutagenesis, expressing the mutant cytochromes in COS-1 cells. We report that the activities of both cytochromes depend critically on the identities of the amino acids at positions 117, 209 and 365 and, moreover, that a single mutation in which Phe 209 is substituted by Leu is sufficient to convert the specificity of P450coh from coumarin to steroid hydroxylation.
Similar content being viewed by others
References
Burkhart, B. A., Harada, N. & Negishi, M. J. biol. Chem. 260, 15357–15361 (1985).
Squires, E. J. & Negishi, M. Biochemistry 25, 4913–4918 (1986).
Squires, E. J. & Negishi, M. J. biol. Chem. 263, 4166–4171 (1988).
Harada, N. & Negishi, M. Biochem. Pharm. 37, 4778–4780 (1988).
Lindberg, R., Burkhart, B., Ichikawa, T. & Negishi, M. J. biol. Chem. 264, 6465–6471 (1989).
Negishi, M. et al. Biochemistry 28, 4169–4172 (1989).
Poulos, T. L., Finzel, B. C., Gunsalus, L. C., Wagner, G. C. & Krant, J. J. biol. Chem. 260, 16122–16128 (1985).
Poulos, T. L., Finzel, B. C. & Howard, A. J. J. molec. Biol. 195, 687–700 (1987).
Imai, Y. & Nakamura, M. FEBS Lett. 234, 313–315 (1988).
Ishida, N. et al. Biochem. biophys. Res. Commun. 155, 317–323 (1988).
Atkins, W. M. & Sligar, S. G. J. biol. Chem. 263, 18842–18849 (1988).
Atkins, W. M. & Sligar, S. G. J. Am. chem. Soc. 111, 2715–2717 (1989).
Sanger, F., Coulson, A. R., Barrel, B. G., Smith, A. J. H. & Roe, B. A. J. molec. Biol. 259, 1239–1250 (1980).
Soyampayac, L. M. & Donna, K. J. Proc. natn. Acad. Sci. U.S.A. 78, 7575–7578 (1981).
Luthman, H. & Magnnson, G. Nucleic Acids Res. 11, 1295–1308 (1983).
Harada, N. & Negishi, M. J. biol. Chem. 259, 12285–12290 (1984).
Kaipainen, P., Koivusaari, V. & Lang, M. Comp. Biochem. Physiol. 81C, 293–296 (1985).
Ozols, J. & Johnson, E. F. J. biol. Chem. 256, 11405–11408 (1981).
Fujii-Kuriyama, Y., Mizukami, Y., Kawajiri, K., Sogawa, K. & Muramatsu, M. Proc. natn. Acad. Sci. U.S.A. 79, 2793–2797 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindberg, R., Negishi, M. Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature 339, 632–634 (1989). https://doi.org/10.1038/339632a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/339632a0
- Springer Nature Limited
This article is cited by
-
Functioning of drug-metabolizing microsomal cytochrome P450s: In silico probing of proteins suggests that the distal heme ‘active site’ pocket plays a relatively ‘passive role’ in some enzyme-substrate interactions
In Silico Pharmacology (2016)
-
Light and auxin responsive cytochrome P450s from Withania somnifera Dunal: cloning, expression and molecular modelling of two pairs of homologue genes with differential regulation
Protoplasma (2015)
-
Molecular recognition using corona phase complexes made of synthetic polymers adsorbed on carbon nanotubes
Nature Nanotechnology (2013)
-
Engineering and assaying of cytochrome P450 biocatalysts
Analytical and Bioanalytical Chemistry (2008)
-
Cytochrome p450 enzymes in the generation of commercial products
Nature Reviews Drug Discovery (2002)